Johnson & Johnson's major HIV vaccine trial failed, and HIV vaccine development still faces challenges
Comparison of EGFR Exon20 inhibitors: Johnson & Johnson Amivantamab vs Takeda Mobocertinib
Johnson & Johnson/Theravance ulcerative colitis drug idencitinib failed Phase II clinical trial
Johnson & Johnson's new oral drug for multiple sclerosis, Ponvory, receives UK approval
Top 20 pharmaceutical companies in revenue: Johnson & Johnson, Roche, Pfizer, Bayer...
Johnson & Johnson's Rybrevant treatment of METex14 mutant lung cancer Phase 1 trial achieves positive results
The TOP10 ranking of multinational pharmaceutical companies has once again become Johnson
Aiming at the 20 billion hepatitis B track, two new drugs from Johnson & Johnson have been included in the CDE to be a breakthrough treatment!
Three-year extended phase data of Johnson & Johnson's Starnox study: showing sustained symptom relief
Named by the State Drug Administration: Johnson & Johnson, Philips, Stryker...
Johnson & Johnson and 3 distributors agree to pay US$26 billion to reach an opioid settlement agreement
Pfizer and Johnson & Johnson reach a settlement in the Remicade generic drug lawsuit
There is no blockbuster yet. Johnson & Johnson, Roche, and GSK have joined. Which drugs in the field of hepatitis B are worth looking forward to?
FinishMaster announces the completion of the acquisition of the automotive and industrial coatings business of Johnson, Michigan
Two Johnson & Johnson drugs are planned to be included in breakthrough therapy to treat chronic hepatitis B
JAMA: AstraZeneca, Janssen/Johnson & Johnson COVID-19 vaccine causes cerebral venous sinus thrombosis and thrombocytopenia to add new evidence
billion; Johnson & Johnson’s Q2 revenue is US$23.3 billion, a year-on-year increase of 27.1%
Johnson & Johnson 2021 semi-annual report: revenue of 45.6 billion US dollars, medical equipment strong recovery, drug growth rate of 13%
Johnson & Johnson's New Coronary Pneumonia Vaccine Receives Emergency Use Authorization by the U.S. Food and Drug Administration (FDA)
Results of winning bids for major consumables: Medtronic, Johnson & Johnson, Lepu...